Skip to main content
. 2016 Aug 6;7(1):73–79. doi: 10.1016/j.apsb.2016.05.003

Table 2.

COX inhibition data of 2,3-diaryl-3H-imidazo[4,5-b]pyridine derivatives.

Compd. IC50 (µmol/L)
Selectivity ratio
COX-1 COX-2 COX-2/COX-1
3a 10.0±0.01 35.9±2.0 3.59
3b 15.0±0.13 NA NA
3c 36.0±1.4 15.1±0.9 0.42
3d 42.7±2.5 25.6±1.0 0.60
3e 16.8±0.1 279.3±7.2 16.58
3f 21.8±1.1 9.2±0.02 0.42
3g 19.1±0.3 22.4±2.5 1.17
3h 18.5±0.00 15.4±3.1 0.83
Indomethacin 0.0067±0.00 0.048±0.00 7.16
Celecoxib 15±0.6 0.042±0.00 0.0028

NA: not achieved at the tested concentrations.